so how does it work? as coronavirus replicates itself inside your body, these antiviral pills trick it into using the drug, which then inserts errors into the virus s genetic code, blocking the virus from replicating. it completely corrupts the genome of the virus so it can t replicate, and that s the beauty. and then, even if the virus mutates, it could be still useful. people are now talking about this, that if we have another coronavirus pandemic in the future, this drug will still work for that coronavirus. because it is agnostic to variants. there are existing clinic based intravenous treatments which are even more effective, but this appears to be the first pill to treat covid, and as long as it s taken early on could offer an alternative at roughly a third of the price at $700 per treatment. accessibility is a problem with a monoclonal antibody. for this one, it s a simple pill
this drug will still work for that coronavirus. because it is agnostic to variants. there are existing clinic based intravenous treatments which are even more effective, but this appears to be the first pill to treat covid, and as long as it s taken early on could offer an alternative at roughly a third of the price at $700 per treatment. accessibility is a problem with a monoclonal antibody. for this one, it s a simple pill so obviously a lot easier to administer and a lot easier to administer as an outpatient as well. merck hopes 10 million courses of the treatment will be available by the end of the year. it has agreed to supply the us with close to 2 million, and to license the drug to several india based generic drug makers, which could supply it to low and middle income countries. for countries that don t have the vaccine available, this could be another stopgap. the us authorities say the drug is no substitute
it could be still useful. people are now talking about this, that if we have another coronavirus pandemic in the future, this drug will still work for that coronavirus. because it is agnostic to variants. there are existing clinic based intravenous treatments which are even more effective, but this appears to be the first pill to treat covid, and as long as it s taken early on could offer an alternative at roughly a third of the price at $700 per treatment. accessibility is a problem with a monoclonal antibody. for this one, it s a simple pill so obviously a lot easier to administer and a lot easier to administer as an outpatient as well. merck hopes 10 million courses of the treatment will be available by the end of the year. it has agreed to supply the us with close to 2 million, and to license the drug to several india based generic drug makers, which could supply it to low and middle income countries.
replicating- code, blocking the virus from re-ulicatin. , , ., replicating. it corrupts the genome ofthe replicating. it corrupts the genome of the virus replicating. it corrupts the genome of the virus so replicating. it corrupts the genome of the virus so it replicating. it corrupts the genome of the virus so it can t replicating. it corrupts the genome of the virus so it can t replicate, i of the virus so it can t replicate, and that of the virus so it can t replicate, and that is of the virus so it can t replicate, and that is the beauty. and then, even and that is the beauty. and then, even if and that is the beauty. and then, even if the and that is the beauty. and then, even if the virus mutates, it could be still even if the virus mutates, it could be still useful. people are now talking be still useful. people are now talking about this, that if we have another talking about this, that if we have another coronavirus pandemic in the future, another coronav
it completely corrupts the genome of the virus so it can t replicate, and that s the beauty. and then, even if the virus mutates, it could be still useful. people are now talking about this, that if we have another coronavirus pandemic in the future, this drug will still work for that coronavirus. because it is agnostic to variants. there are existing clinic based intravenous treatments which are even more effective, but this appears to be the first pill to treat covid, and as long as it s taken early on could offer an alternative at roughly a third of the price at $700 per treatment. accessibility is a problem i with a monoclonal antibody. for this one, it s a simple pill so obviously a lot easier- to administer and a lot easier to administer as an outpatient as well. merck hopes 10 million courses of the treatment will be available by the end of the year. it has agreed to supply the us with close to 2 million,